AB2 Bio is a Phase 3 clinical-stage biotech company developing innovative therapies for the treatment of severe systemic autoinflammatory diseases, including rare diseases with high unmet medical needs. AB2 Bio is building a late-stage clinical pipeline with Tadekinig alfa, a novel IL-18 binding protein with established clinical proof-of-concept in three, life-threatening orphan autoinflammatory indications. The Company is also advancing Tadekinig alfa in preclinical development in oncology and COVID-19 cytokine release syndrome. AB2 Bio is located in the Innovation Park at the Ecole Polytechnique Federale de Lausanne (EPFL), Switzerland.
View Top Employees from AB2 Bio Ltd.| Website | http://ab2bio.com |
| Revenue | $4 million |
| Employees | 10 (6 on RocketReach) |
| Founded | 2010 |
| Address | Ep Fl Innovation Park Bldg B4th Florida, Lausanne, Vaud 1015, CH |
| Phone | +41 21 694 00 40 |
| Fax | +41 21 694 00 41 |
| Technologies |
JavaScript,
HTML,
Google Analytics
+3 more
(view full list)
|
| Industry | Research, Manufacturing General, Biotechnology, Drug Discovery, Manufacturing, Science and Engineering, Health Care, Medical, Therapeutics |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular AB2 Bio Ltd. employee's phone or email?
AB2 Bio Ltd. Questions
The AB2 Bio Ltd. annual revenue was $4 million in 2024.
Fernando Cunha is the CFO of AB2 Bio Ltd..
6 people are employed at AB2 Bio Ltd..
AB2 Bio Ltd. is based in Lausanne, Vaud.
The NAICS codes for AB2 Bio Ltd. are [3254, 325, 32541, 32].
The SIC codes for AB2 Bio Ltd. are [28, 283].
Top AB2 Bio Ltd. Employees
-
2
-
5+5
-
22
-
1
-
Related Companies
